Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01383-18. doi: 10.1128/AAC.01383-18. Print 2018 Nov.

PMID:
30126955
2.

Failure in TB control: why should the rapid diagnostic test bear the blame?

Atre S.

Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1109-1110. doi: 10.5588/ijtld.18.0314. No abstract available.

PMID:
30092883
3.

Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):800-806. doi: 10.5588/ijtld.18.0026.

4.

How feasible is pharmaceutical regulation in India?

Atre S.

Lancet Glob Health. 2018 Feb;6(2):e143. doi: 10.1016/S2214-109X(17)30491-6. No abstract available.

5.

Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.

Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte A, Gupta A, Gupte N, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1280-1287. doi: 10.5588/ijtld.17.0474.

6.

The significance of cytomegalovirus in children with pneumonia admitted for mechanical ventilation.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):800-806. doi: 10.5588/ijtld.17.0026.

PMID:
29297442
7.

A qualitative study exploring factors influencing clinical decision-making for influenza-like illness in Solapur city, Maharashtra, India.

Ahankari AS, Myles PR, Tsang S, Khan F, Atre S, Langley T, Kudale A, Bains M.

Anthropol Med. 2017 Jul 3:1-22. doi: 10.1080/13648470.2017.1321459. [Epub ahead of print]

PMID:
28671478
8.

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, McNerney R, Murray M, Furin J, Nardell EA, London L, Lessem E, Theron G, van Helden P, Niemann S, Merker M, Dowdy D, Van Rie A, Siu GK, Pasipanodya JG, Rodrigues C, Clark TG, Sirgel FA, Esmail A, Lin HH, Atre SR, Schaaf HS, Chang KC, Lange C, Nahid P, Udwadia ZF, Horsburgh CR Jr, Churchyard GJ, Menzies D, Hesseling AC, Nuermberger E, McIlleron H, Fennelly KP, Goemaere E, Jaramillo E, Low M, Jara CM, Padayatchi N, Warren RM.

Lancet Respir Med. 2017 Mar 15. pii: S2213-2600(17)30079-6. doi: 10.1016/S2213-2600(17)30079-6. [Epub ahead of print] Review.

PMID:
28344011
9.

Modelling approaches for tuberculosis: are they realistic?

Atre S.

Lancet Glob Health. 2017 Mar;5(3):e268. doi: 10.1016/S2214-109X(17)30048-7. No abstract available.

10.

Tuberculosis burden in India's private sector.

Atre S.

Lancet Infect Dis. 2016 Dec;16(12):1328-1329. doi: 10.1016/S1473-3099(16)30470-4. Epub 2016 Nov 15. No abstract available. Erratum in: Lancet Infect Dis. 2017 Jan;17(1):17.

PMID:
27998589
11.

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice.

Uplekar M, Atre S, Wells WA, Weil D, Lopez R, Migliori GB, Raviglione M.

Eur Respir J. 2016 Dec;48(6):1571-1581. doi: 10.1183/13993003.00956-2016. Epub 2016 Oct 20. Review.

12.

Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.

Atre SR, Murray MB.

J Public Health Policy. 2016 May 6. doi: 10.1057/jphp.2016.14. [Epub ahead of print] Review.

PMID:
27153155
13.

Notification of multidrug-resistant tuberculosis cases and treatment outcomes in the private sector.

Atre S.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1126. doi: 10.5588/ijtld.15.0365. No abstract available.

PMID:
26260837
14.
15.

Addressing policy needs for prevention and control of type 2 diabetes in India.

Atre S.

Perspect Public Health. 2015 Sep;135(5):257-63. doi: 10.1177/1757913914565197. Epub 2015 Jan 13. Review.

PMID:
25585513
16.

Private players in tuberculosis control: will negotiation help to maintain the symbiosis in the ecosystem?

Atre S.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1524. doi: 10.5588/ijtld.14.0601. No abstract available.

PMID:
25517824
17.

Treatment of two canals in all mandibular incisor teeth in the same patient.

Kokane VB, Patil SN, Gunwal MK, Kubde R, Atre S.

Case Rep Dent. 2014;2014:893980. doi: 10.1155/2014/893980. Epub 2014 Nov 16.

18.

Controlling tuberculosis in India: a need to implement an electronic recording and reporting system.

Atre S.

Int J Tuberc Lung Dis. 2014 Oct;18(10):1259. doi: 10.5588/ijtld.14.0417. No abstract available.

PMID:
25216845
19.
20.

Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India.

Atre SR, D'Souza DT, Vira TS, Chatterjee A, Mistry NF.

Indian J Public Health. 2011 Jan-Mar;55(1):14-21. doi: 10.4103/0019-557X.82536.

21.

Gender and community views of stigma and tuberculosis in rural Maharashtra, India.

Atre S, Kudale A, Morankar S, Gosoniu D, Weiss MG.

Glob Public Health. 2011;6(1):56-71. doi: 10.1080/17441690903334240.

PMID:
21509994
22.

Robust, functionalizable, nanometer-thick poly(acrylic acid) films spontaneously assembled on oxidized aluminum substrates: structures and chemical properties.

Koo E, Yoon S, Atre SV, Allara DL.

Langmuir. 2011 Apr 5;27(7):3638-53. doi: 10.1021/la104840c. Epub 2011 Mar 7.

PMID:
21381773
23.

Observations on categorisation of new TB cases: implications for controlling drug resistance.

Atre SR, D'Souza DT, Dholakia YN, Mistry NF.

Int J Tuberc Lung Dis. 2007 Oct;11(10):1152-3.

24.

Tuberculosis control: do we want it?

Atre SR.

Int J Tuberc Lung Dis. 2005 Sep;9(9):1059. No abstract available.

PMID:
16158904
25.

Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.

Atre SR, Mistry NF.

J Public Health Policy. 2005 Apr;26(1):96-114.

PMID:
15906879
26.

Cultural concepts of tuberculosis and gender among the general population without tuberculosis in rural Maharashtra, India.

Atre SR, Kudale AM, Morankar SN, Rangan SG, Weiss MG.

Trop Med Int Health. 2004 Nov;9(11):1228-38.

Supplemental Content

Support Center